![](https://www.outsourcing-pharma.com/var/wrbm_gb_food_pharma/storage/images/publications/pharmaceutical-science/outsourcing-pharma.com/headlines/contract-manufacturing-logistics/work-on-novo-nordisk-s-56-acre-site-has-begun-with-4.1bn-investment/17579668-1-eng-GB/Work-on-Novo-Nordisk-s-56-acre-site-has-begun-with-4.1BN-investment.jpg)
5 Novo Nordisk announces $4.1BN investment to expand US manufacturing capacity
This significant expansion aims to enhance the production of injectable treatments for obesity and chronic diseases. The new facility, spanning 1.4 million square feet, will double the footprint of Novo Nordisk’s existing facilities in North Carolina, …